NP / PA
Aulert, Michael
Aulert, Michael was paid $255K by Medicaid between Feb 2020 and Dec 2024, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 69% of everything it billed.
33Billing provider infoAULERT, MICHAEL
ST CHARLES, IL 60174
ST CHARLES, IL 60174
33aNPI1285117754assigned 09/11/2018
33bProvider typeFamily Nurse Practitioner
28Total paid$255K
24GClaims3,764
24DCodes billed7
24AFirst – last monthFeb 2020 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#249 of 3,353
Median peer was paid$25K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 225 | $12K | |
| 2021 | 624 | $42K | |
| 2022 | 449 | $34K | |
| 2023 | 1,009 | $65K | |
| 2024incomplete | 1,457 | $103K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 69% | 2,284 | 2,090 | $175K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10% | 520 | 476 | $26K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 10% | 362 | 315 | $26K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.4% | 327 | 284 | $16K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.6% | 220 | 199 | $9K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 13 | 13 | $2K |
| 90686 | <1% | 38 | 13 | $498.93 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.